Author Topic: Phase 2b trial for MIS416 for SPMS  (Read 130 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8564
  • MS diagnosed 1980
  • Location: Pacific Northwest
MIS416 failed Phase II clinical trial
« on: August 09, 2018, 08:55:03 pm »
This is old news but may have some relevance to the US national news just now--from the National MS Society Website:


https://www.nationalmssociety.org/About-the-Society/News/Results-Announced-from-Phase-2-Trial-of-MIS416-in


From the Washington Post (August 8, 2016) there is the news that Representative Chris Collins (Rep., NY) is under indictment for insider training. It seems he was a stockholder in Innate Immunotherapeutics, which was developing a new drug for secondary progressive MS. He had knowledge about the failure of the clinical trial and passed that information along to relatives, advising them to dump their stock, before this was public knowledge.  Although the drug hasn't been named, my guess is that it was MIS 416.


https://www.washingtonpost.com/business/2018/08/08/rep-christopher-collins-r-ny-charged-with-insider-trading-federal-prosecutors-announce/?utm_term=.ded4bf4c9ef1
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.